118 related articles for article (PubMed ID: 16401916)
1. Can the effect of antibiotherapy and anti-inflammatory therapy on serum PSA levels discriminate between benign and malign prostatic pathologies?
Erol H; Beder N; Calişkan T; Dündar M; Unsal A; Culhaci N
Urol Int; 2006; 76(1):20-6. PubMed ID: 16401916
[TBL] [Abstract][Full Text] [Related]
2. Impacts of antibiotic and anti-inflammatory therapies on serum prostate-specific antigen levels in the presence of prostatic inflammation: a prospective randomized controlled trial.
Ugurlu O; Yaris M; Oztekin CV; Kosan TM; Adsan O; Cetinkaya M
Urol Int; 2010; 84(2):185-90. PubMed ID: 20215823
[TBL] [Abstract][Full Text] [Related]
3. Serum PSA and percent free PSA value changes after antibiotic treatment. A diagnostic method in prostate cancer suspects with asymptomatic prostatitis.
Kobayashi M; Nukui A; Morita T
Urol Int; 2008; 80(2):186-92. PubMed ID: 18362491
[TBL] [Abstract][Full Text] [Related]
4. Significance of histological prostatitis in patients with urinary retention and underlying benign prostatic hyperplasia or adenocarcinoma of the prostate.
van Vuuren SP; Heyns CF; Zarrabi AD
BJU Int; 2012 Apr; 109(8):1194-7. PubMed ID: 21851551
[TBL] [Abstract][Full Text] [Related]
5. Effect of prostatic massage on serum complexed prostate-specific antigen levels.
Tarhan F; Orçun A; Küçükercan I; Camursoy N; Kuyumcuoğlu U
Urology; 2005 Dec; 66(6):1234-8. PubMed ID: 16360449
[TBL] [Abstract][Full Text] [Related]
6. Effects of antibacterial therapy on PSA change in the presence and absence of prostatic inflammation in patients with PSA levels between 4 and 10 ng/ml.
Kaygisiz O; Uğurlu O; Koşan M; Inal G; Oztürk B; Cetinkaya M
Prostate Cancer Prostatic Dis; 2006; 9(3):235-8. PubMed ID: 16718277
[TBL] [Abstract][Full Text] [Related]
7. Antimicrobial therapy for asymptomatic patients with elevated prostate-specific antigen: can the change in prostate-specific antigen reliably guide prostate biopsy decisions?
Torky M; Mosharafa A; Emran A; Kamal A; Abdelhamid M
Urol Int; 2011; 87(4):416-9. PubMed ID: 21934292
[TBL] [Abstract][Full Text] [Related]
8. Effect of NIH-IV prostatitis on free and free-to-total PSA.
Stancik I; Lüftenegger W; Klimpfinger M; Müller MM; Hoeltl W
Eur Urol; 2004 Dec; 46(6):760-4. PubMed ID: 15548444
[TBL] [Abstract][Full Text] [Related]
9. Comparison of percent free prostate-specific antigen levels in men with benign prostatic hyperplasia treated with finasteride, terazosin, or watchful waiting.
Keetch DW; Andriole GL; Ratliff TL; Catalona WJ
Urology; 1997 Dec; 50(6):901-5. PubMed ID: 9426721
[TBL] [Abstract][Full Text] [Related]
10. Prostate tissue and serum markers.
Mazzucchelli R; Colanzi P; Pomante R; Muzzonigro G; Montironi R
Adv Clin Path; 2000 Jul; 4(3):111-20. PubMed ID: 11080790
[TBL] [Abstract][Full Text] [Related]
11. [Retropubic adenomectomy in patients with a high level of prostate-specific antigen after prostatic biopsy].
Veliev EI; Kotov SV; Golubtsova EN; Sokolov AE; Bogdanov AB; Avakian AIu
Urologiia; 2012; (1):59-63. PubMed ID: 22646005
[TBL] [Abstract][Full Text] [Related]
12. Ratio of free-to-total prostate specific antigen in serum cannot distinguish patients with prostate cancer from those with chronic inflammation of the prostate.
Jung K; Meyer A; Lein M; Rudolph B; Schnorr D; Loening SA
J Urol; 1998 May; 159(5):1595-8. PubMed ID: 9554361
[TBL] [Abstract][Full Text] [Related]
13. [Effects of antibiotic and anti-inflammatory treatment on serum PSA and free PSA levels in patients with chronic prostatitis IIIA].
Wang W; Hu WL; Yang H; Qiu XF; Zhang CZ
Zhonghua Nan Ke Xue; 2006 Sep; 12(9):787-90. PubMed ID: 17009527
[TBL] [Abstract][Full Text] [Related]
14. Reduction of PSA values by combination pharmacological therapy in patients with chronic prostatitis: implications for prostate cancer detection.
Magri V; Trinchieri A; Montanari E; Del Nero A; Mangiarotti B; Zirpoli P; de Eguileor M; Marras E; Ceriani I; Vral A; Perletti G
Arch Ital Urol Androl; 2007 Jun; 79(2):84-92. PubMed ID: 17695414
[TBL] [Abstract][Full Text] [Related]
15. Detection of prostatic carcinoma: the role of TRUS, TRUS guided biopsy, digital rectal examination, PSA and PSA density.
Men S; Cakar B; Conkbayir I; Hekimoglu B
J Exp Clin Cancer Res; 2001 Dec; 20(4):473-80. PubMed ID: 11876539
[TBL] [Abstract][Full Text] [Related]
16. Do changes in a high serum prostate-specific antigen level and the free/total prostate-specific antigen ratio after antibiotic treatment rule out biopsy and the suspicion of cancer?
Dirim A; Tekin MI; Koyluoglu E; Oguzulgen AI; Peskircioglu L; Ozkardes H
Urol Int; 2009; 82(3):266-9. PubMed ID: 19440011
[TBL] [Abstract][Full Text] [Related]
17. Treatment of chronic bacterial prostatitis with levofloxacin and ciprofloxacin lowers serum prostate specific antigen.
Schaeffer AJ; Wu SC; Tennenberg AM; Kahn JB
J Urol; 2005 Jul; 174(1):161-4. PubMed ID: 15947609
[TBL] [Abstract][Full Text] [Related]
18. Stability of free and total prostate specific antigen in serum from patients with prostate carcinoma and benign hyperplasia.
Paus E; Nilsson O; Børmer OP; Fosså SD; Otnes B; Skovlund E
J Urol; 1998 May; 159(5):1599-605. PubMed ID: 9554362
[TBL] [Abstract][Full Text] [Related]
19. Prostate specific antigen decrease and prostate cancer diagnosis: antibiotic versus placebo prospective randomized clinical trial.
Stopiglia RM; Ferreira U; Silva MM; Matheus WE; Denardi F; Reis LO
J Urol; 2010 Mar; 183(3):940-4. PubMed ID: 20089269
[TBL] [Abstract][Full Text] [Related]
20. Comparison of the clinical value of complexed PSA and total PSA in the discrimination between benign prostatic hyperplasia and prostate cancer.
Froehner M; Hakenberg OW; Koch R; Schmidt U; Meye A; Wirth MP
Urol Int; 2006; 76(1):27-30. PubMed ID: 16401917
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
